SDSL and early-onset autosomal dominant Alzheimer disease: Glutamate can undergo structural conversion via glutamate racemase and interactions with gut bacteria such as Brevibacterium avium, potentially influencing the glutamate NMDA receptor and cognitive functions in patients with Alzheimer disease [36].